The demonstration of value and optimal access is the most fundamental challenge and opportunity for any brand irrespective of where it is in its lifecycle. We support biopharmaceutical companies to optimize pricing and access for therapeutics by dovetailing these with overall commercialisation objectives, contextualised within market specific evidence requirement, and alignment with payer goals.

Our expertise in pricing and access paired with a strategy consultant approach, allow us to help our clients navigate complex pricing and market access environments. Our deep market specific insights help shape and refine pricing and access strategies and support their implementation in health technology evaluations. The mix of pricing and market access, and broader commercial expertise allows us to serve our clients market access, clinical and commercial teams.

Market Access Strategy Development

Ensuring products can achieve their full potential and deliver the most benefits to patients across markets

  • Market Access Opportunity Assessment
  • Primary Market Research (Payer & KOL)
  • Pricing assessments (analogue & qual. PMR)
  • Indication prioritization & sequencing

Development of Core Deliverables & Launch Readiness

Turning complex and heterogeneous challenges into simple and digestible deliverables for teams to leverage

  • Payer Value Story & Objection handler
  • Negotiation strategy guide  playbooks
  • Managed Entry Agreement (MEA) frameworks
  • Contracting & Tendering playbooks

Localization of Access Strategies & Execution Support

Supporting and empowering local tam to optimally execute ambitious access goals

  • Training & immersion into Global strategic deliverables
  • Localization of access strategies
  • Mock payer negotiations

Contact information

Fill in the contact form and a member of your team will get back to you

  • Eradigm Consulting Fora,
    241 Southwark Bridge Road,
    London, SE1 6FP
  • Eradigm Consulting Inc. WeWork
    Tower49 – 12 E 49th Street
    New York NY 10017, USA